MultiplAI Health
MultiplAI Health turns a single blood sample into an early, actionable risk assessment for cardiovascular and other complex diseases. The company uses whole-blood liquid biopsy based on genomic RNA sequencing, proprietary data transformation, and deep learning models to analyze comprehensive blood biomarkers. MultiplAI Health operates as a preventive-medicine, B2B SaaS/diagnostics provider that supports remote sampling and continuous testing for screening and post-treatment monitoring. Its approach is laboratory-validated with ongoing clinical studies to further validate technical performance in the cardiovascular space. The solution targets healthcare providers and screening programs seeking scalable, noninvasive early-detection tools.
MultiplAI Health
MultiplAI Health turns a single blood sample into an early, actionable risk assessment for cardiovascular and other complex diseases. The company uses whole-blood liquid biopsy based on genomic RNA sequencing, proprietary data transformation, and deep learning models to analyze comprehensive blood biomarkers. MultiplAI Health operates as a preventive-medicine, B2B SaaS/diagnostics provider that supports remote sampling and continuous testing for screening and post-treatment monitoring. Its approach is laboratory-validated with ongoing clinical studies to further validate technical performance in the cardiovascular space. The solution targets healthcare providers and screening programs seeking scalable, noninvasive early-detection tools.